Rezlidhia (olutasidenib) / Rigel, Novo Nordisk  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rezlidhia (olutasidenib) / Rigel
NCT06161974: Study of Olutasidenib and Temozolomide in HGG

Not yet recruiting
2
60
Europe, Canada, US, RoW
Olutasidenib + TMZ
Rigel Pharmaceuticals, Nationwide Children's Hospital
High Grade Glioma, Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, Diffuse Intrinsic Pontine Glioma, WHO Grade III Glioma, WHO Grade IV Glioma, Metastatic Brain Tumor, Diffuse Midline Glioma, H3 K27M-Mutant, Thalamus Tumor, Spinal Tumor, IDH1 Mutation, IDH1 R132, IDH1 R132C, IDH1 R132H, IDH1 R132S, IDH1 R132G, IDH1 R132L, Oligodendroglioma
06/29
06/35
2018-001796-21: A Study of FT-2102 in Patients with Advanced Solid Tumors and Gliomas

Not yet recruiting
1/2
200
Europe
olutasidenib, Azacitidine, Nivolumab, Gemcitabine, Cisplatin, FT-2102, Capsule, hard, Powder for suspension for injection, Concentrate for solution for infusion, Powder for solution for infusion, Vidaza, Opdivo, Gemcitabine, Cisplatin
Forma Therapeutics, Inc., FORMA Therapeutics, Inc., Forma Therapeutics, Inc., FORMA Therapeutics, Inc.
Advanced Solid Tumors and Gliomas with an IDH1 Mutation, Advanced Solid Tumors and Gliomas, Diseases [C] - Cancer [C04]
 
 
2102-HEM-101, NCT02719574 / 2017-001051-32: Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation

Completed
1/2
336
Europe, Canada, US, RoW
FT-2102 (olutasidenib), Azacitidine, Vidaza, Cytarabine
Forma Therapeutics, Inc.
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome
12/23
01/24
NCT06445959: Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib

Not yet recruiting
1/2
78
US
Olutasidenib, Venetoclax, ABT-199, GDC-0199, Decitabine, Dacogen
M.D. Anderson Cancer Center, Rigel Pharmaceuticals,Inc.
Mutant IDH1 Inhibitor Olutasidenib
06/27
06/29

Download Options